Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

(2016) Dena Ettehad et al.   LANCET

Prevalence of Masked Hypertension and Its Association With Subclinical Cardiovascular Disease in African Americans: Results From the Jackson Heart Study

(2016) Nicole Redmond et al.   Journal of the American Heart Association

Long term antihypertensive drug use and prostate cancer risk: A 9-year population-based cohort analysis

(2015) Pei-Ying Pai et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Effects of blood pressure lowering on outcome incidence in hypertension

(2015) Costas Thomopoulos et al.   JOURNAL OF HYPERTENSION

Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients

(2015) Hua Lu et al.   OncoTargets and Therapy

Combining Other Antihypertensive Drugs With β-Blockers in Hypertension: A Focus on Safety and Tolerability

(2014) Tiffany R. Richards et al.   CANADIAN JOURNAL OF CARDIOLOGY

Home Blood Pressure and Cardiovascular Outcomes in Patients During Antihypertensive Therapy

(2014) Kazuomi Kario et al.   HYPERTENSION

Calcium channel blockers and prostate cancer

(2014) Kevin R. Loughlin   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Angiotensin Receptor Blockers and Risk of Prostate Cancer Among United States Veterans

(2013) Gowtham A. Rao et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial

(2013) Hiddo J Lambers Heerspink et al.   European Journal of Preventive Cardiology

Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study

(2012) Jesper Hallas et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer—a systematic review and meta-analysis

(2012) Charalampos Siristatidis et al.   HUMAN REPRODUCTION UPDATE

Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer

(2012) Laurent Azoulay et al.   PLoS One

Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database

(2012) K. Bhaskaran et al.   BMJ-British Medical Journal

Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk

(2011) Ilke Sipahi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies

(2011) C. Yoon et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case–control study

(2011) Kimmo J. Kemppainen et al.   CANCER CAUSES & CONTROL

The Effect of Antihypertensive Agents on Insulin Sensitivity, Lipids and Haemostasis

(2010) Asterios Karagiannis et al.   Current Vascular Pharmacology

Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer

(2008) Ronald van der Knaap et al.   CANCER

Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

(2008) Carmen Rodriguez et al.   CANCER CAUSES & CONTROL

Long-term use of antihypertensive drugs and risk of cancer

(2008) Themistocles L. Assimes et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY